Background: Patent foramen ovale (PFO) is an interatrial communication whose
management is controversial. Several manufacturers have submitted protocols for Food and …

Patent foramen ovale (PFO) is a common developmental anomaly that allows for the
passage of blood and other substances from the venous to the arterial circulation. The study …

Background Patent foramen ovale (PFO) has been linked to cryptogenic stroke, and closure
has been reported to improve clinical outcomes. However, there are no clear guidelines to …

Percutaneous closure of patent foramen ovale (PFO) has been proposed as the treatment of
choice for young high-risk patients who suffered cryptogenic stroke and/or peripheral …

Introduction: Patent foramen ovale (PFO) is a common congenital cardiac abnormality and
that has been associated with several disease processes including transient ischemic …

Paradoxical embolism through a patent foramen ovale (PFO) was described first in 1877. 1 It
was never doubted that this could lead to a stroke. However, it was more than 100 years …

Background Patent foramen ovale (PFO) has been associated with paradoxical embolism
leading to stroke/transient ischemic attack, migraine, and neurological decompression …

The patent foramen ovale (PFO) is a common anatomical variant with a prevalence of 25–
30%. It may go unnoticed or become symptomatic in terms of systemic embolism (mostly …

Technological developments in recent years have made percutaneous patent foramen ovale
(PFO) closure a feasible and safe treatment option. Procedural competency demands a …

Background Patent foramen ovale (PFO) closure after a cryptogenic cerebral ischemic event
is a routinely procedure. The most used device is Amplatzer™ PFO Occluder 25 mm, but …